Roche: Nine-month sales in line with expectations
NEUTRAL, Fair Value CHF252 (+3%)
Roche has reported 9-month sales figures this morning, very much in line with expectations. Very few comments are required for Pharmaceuticals while reassuring messages were received for Diagnostics that seem to have picked up somewhat to stand at the top-end of the sector. Full-year guidance is unchanged.
Full report available to subscribers
Please contact firstname.lastname@example.org